SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-078484
Filing Date
2022-03-17
Accepted
2022-03-17 17:29:07
Documents
16
Period of Report
2022-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d266766d8k.htm   iXBRL 8-K 27637
2 EX-1.1 d266766dex11.htm EX-1.1 178156
3 EX-5.1 d266766dex51.htm EX-5.1 9983
7 GRAPHIC g266766wilson2.jpg GRAPHIC 1584
8 GRAPHIC g266766wisonl1.jpg GRAPHIC 3739
  Complete submission text file 0001193125-22-078484.txt   405462

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aadi-20220317.xsd EX-101.SCH 2848
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20220317_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20220317_pre.xml EX-101.PRE 11702
10 EXTRACTED XBRL INSTANCE DOCUMENT d266766d8k_htm.xml XML 3480
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 22750003
SIC: 2834 Pharmaceutical Preparations